Summary
Several human cell lines (normal and neoplastic glia, cerebral metastases from adenocarcinoma, fibroblasts) were incubated with sera from patients with well and poorly differentiated glioma and with sera from healthy donors and then stained with PAP complex to define and localize the antibody reaction with cell surface antigens by means of electron microscopy. The sera of glioma patients proved to contain antibodies which bound the tumor-associated antigenic determinants on the cell membranes of gliomas and of cerebral metastases from adenocarcinoma in tissue cultures. Further, absorption testing of the reactive sera on normal brain, well-differentiated astrocytoma and cultured glioblastoma cells, together with cross-reactivity experiments suggests that at least two antigens or groups of antigens are expressed on the glioma cell surface: one shared by well and poorly differentiated glioma cells and the other by poorly differentiated glioma cells and the cells of cerebral metastases from adenocarcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Apuzzo MLJ, Mitchell MS (1981) Immunological aspects of intrinsic glial tumors. J Neurosurg 55:1–18
Apuzzo MLJ, Sheikh KMA, Weiss MH, Heiden JS, Kurze T (1981) The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients. Acta Neurochir 50:181–200
Bender BL, Jaffe R (1979) Effect of fixation on Fc-receptor activity demonstrated by peroxidase. J Histochem Cytochem 27:1055
Bigner DD, Bigner SH, Ponren J, Westermark B, Mahaley MS, Ruoslahti E, Herschman H, Eng LF, Wikstrand CJ (1981) Heterogeneity of genotipic and phenotipic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 40:201–229
Bullard DE, Bigner SH, Bigner DD (1981) The morphologic response of cell lines derived from human gliomas to dibutyryl adenosine 3′,5′-cyclic monophosphate. J Neuropathol Exp Neurol 40:230–246
Caine GD, Weller RO, Davis BE, Cox S (1980) Mechanism of uptake and the fate of serum proteins and horseradish peroxidase in cultured human glioma cells. Acta Neuropathol (Berl) 52:169–177
Coakham HB, Lakshmi MS (1975) Tumor-associated antigen(s) in human astrocytomas. Oncology 31:233–243
Gilden DH, Molenaar I, Devlin M, Eng L, Wroblewka Z (1981) Human Brain in tissue culture. Acta Neuropathol (Berl) 53:327–330
Jacque CM, Kuias M, Poreau A, Raul M, Collier P, Racadot J, Bauman N (1979) GFA and S-100 protein levels as an index for malignancy in human gliomas and neurinomas. J Natl Cancer Inst 62:479–483
Kornblith PL, Dohan FC, Wood WC, Whitman BS (1974) Human astrocytoma serum-mediated immunologic response. Cancer 33:1512–1519
Kornblith PL, Pollok LA, Coakham HB, Quidlen EA, Wood WC (1979) Cytotoxic antibody responses in astrocytoma patients. J Neurosurg 51:47–52
Kumar P (1979) The biology of human brain tumors. Acta Neurochir 50:7–34
Lauro GM, Medolago-Albani L, Solheid C, Di Lorenzo N (1980) Immunohistochemical evaluation of glioma patients sera. Acta Neurol (Napoli) 2:428
Levy NL (1978) Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors. J Immunol 121:903–915
Liao SK, Clarke BJ, Kwong PC, Brickenden A, Gallie BL, Dent PB (1981) Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells. Eur J Immunol 11:450–454
Mahaley MS, Brooks WH, Rozman TL, Bigner DD, Dudka L, Richardson S (1977) Immunobiology of primary intracranial tumors. Part I: Studies of the cellular and humoral general immunocompetence of brain tumor patients. J Neurosurg 46:467–476
Mottet S, Martin-Achard A, de Tribolet N, Diserens AC (1980) Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens. Acta Neurochir 52:19–25
Pfreundschuh M, Shiku H, Takahashi T, Ueda R, Ransohoff J, Oettgen HF, Old LJ (1978) Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci USA 75:5122–5126
Phillips JP, Sujatonod M, Martuza RL, Quidlen EA, Wood WC, Kornblith PL, Dohan FC (1976) Cytotoxic antibodies in preoperative glioma patients: a diagnostic assay. Acta Neurochir 35:43–52
Quidlen EA, Dohan FC, Kornblith PL (1974) Improved assay for cytotoxic antiglioma antibody. Surg Forum 25:464–466
Raff MC, Fields KL, Hakomori SI, Mirsky R, Pruss RM, Winter J (1979) Cell type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res 174:283–308
Schnegg JF, de Tribolet N, Dierens AC, Martin-Achard A, Carrel S (1981) Characterization of a rabbit anti-human malignant glioma antiserum. Int J Cancer 28:265–269
Seeger RC, Rosenblatt HM, Imai K, Ferrone S (1981) Common antigenic determinants on human melanoma, glioma, neuroblastoma and sarcoma cells defined with monoclonal antibodies. Cancer Res 41:2714–2717
Smith BH, Liszczac TM (1980) Target cell factors in the detection of humoral immune responses to human brain tumors. In: Rosenberg SA (ed) Serological analysis of human cancer antigens. Academic Press, New York, pp 37–63
Solheid C, Lauro GM, Palladini G (1976) Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence. J Neurol Sci 30:55–64
Tabuchi K, Kirsch WM (1978) Detection of IgG on glioblastoma cell-surface in vivo. Acta Neurochir 43:93–100
Trouillas P (1973) Immunologie et immunoterapie des tumeurs cerebrales. Etat Actuel Rev Neurol 128:23–38
Wahlstrom T, Linder E, Saksela E, Westmark B (1974) Tumor-specific membrane antigens in established cell lines from gliomas. Cancer 34:274–279
Woosley RE, Mahaley S, Mahaley JL, Miller GM, Brooks WH (1977) Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assay of specific immune responses of brain tumor patients. J Neurosurg 47:871–885
Author information
Authors and Affiliations
Additional information
Supported by P. F. “Controllo della crescita neoplastica of CNR”, Baron Kronaker Fund for Brain Tumor Research, Belgian F. W.GO 3.0058 81, and by grant no. CT81.00248.04 from CNR
Rights and permissions
About this article
Cite this article
Lauro, G.M., Solheid, C., Medolago-Albani, L. et al. Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells. Acta Neuropathol 59, 127–132 (1983). https://doi.org/10.1007/BF00691598
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00691598